But I'm also a bit curious as to the idea itself - could a healthcare-company actually provide this service at the said price with the right staff and technology, or is it simply an overly optimistic setup?
0: http://www.bloomberg.com/view/articles/2016-04-27/theranos-a...
The harder(or maybe impossible) part is collecting clean samples from the fingertip. But maybe theranos will pivot to collect blood via veins, at least for now ?
That of course will reduce their valuation greatly(because people hate vein-puncture, so no frequent blood testing scenarios), but the cheap price could be very valuable to third world countries.
But again, that's just theory.
http://m.upto75.com/Thyrocare/m/6693/Sale_Offer.html is a set of 32 tests that costs roughly 14$ . and this is the most expensive company there is.
The only tech that could make this better is fingertip testing.
Incidentally I noticed that https://www.medichecks.com/ offer " Finger-prick - comprehensive entry-level health screen" analysis for $142. Someone should investigate!
And i've read research about labs-on-chip(theranos like tech) with a price of much less than a cent, per test and it should apply to antibodies.